The last earnings report, released on Feb 26, 2026, exceeded the consensus estimates by 0.01%.On average, the company has fell short of earnings expectations by -0.0233%, based on the last three reports.
Imugene Ltd. has completed 4 stock splits, with the recent split occurring on Jul 02, 2025.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on ASX (AUD).